1. 1/16/2011 1

2. Dr.H.A. Moeeni Isfahan University of Medical Sciences 1/16/2011 2

3.  Over correction  Hyperopic shift  Under correction  Irigular astigmatism  Unstable refraction 1/16/2011 3

4. 4

5.  Corneal staining  Recurrent corneal ulcer  Night glare – light scuter  Hypertrophic scaring  Dificult biometri  Endothelial problems 1/16/2011 5

6. 6

7. 7

8. 8

9. 9

10. 10

11.  Refraitive lens exchange  Myopic  Hyperopic 1/16/2011 11

12.  Surgical complications  Losing accomodation  Vitrous problems (P.V.D)  Retinal problems * CME * RD 1/16/2011 12

13. 1/16/2011 13

14.  Homoplastic corneal inlays  Aphakic and high hyperopic correction 1/16/2011 14

15.  Synthetic inlays *Under the stromal flap * In the stromal pocket 1/16/2011 15

16.  Re epithelialization over the lenticule  Non healing defects  Iinfection  Stromal infiltration 1/16/2011 16

17.  Strmal melting  Dehiscence  Refractive error  Irrigular astigmatism 1/16/2011 17

18.  Epithelial ingrowth  Interface cyst  Sever glare 1/16/2011 18

19. 1/16/2011 19

20. 1/16/2011 20

21.  Loss of best corrected V.A  Anterior chamber perforation  Microbial keratitis  Implant expulsion 1/16/2011 21

22.  Shalow ring segment placement  Redured corneal sensitvity  Induced astigmatism  Deep neovascularization 1/16/2011 22

23.  Persistent epithelial defect  Iritis ( uveitis )  Diplopia  Difficalty in night vision 1/16/2011 23

24.  Blurry vision  Glare  Haloes  Fluctuation Far near near  Photophobia 1/16/2011 24

25. 1/16/2011 25

26. 1/16/2011 26

27. 1/16/2011 27

28. 1/16/2011 28

29. 1/16/2011 29

30. 1/16/2011 30

31.  Over correction  Under correction  Central islands  Optical aberrations 1/16/2011 31

32.  Glare  Ghost images  Haloes Most seen in smaller zones large pupilary diameter 1/16/2011 32

33.  Decentered ablation  Corneal haze * Normal healers * Inadequeate healers * Aggressive healers 1/16/2011 33

34. 1/16/2011 34

35.  Epitlelial defect * Keratoconjunctivitis sicca * Autoimmune disease * Diabeties 1/16/2011 35

36. 1/16/2011 36

37. 1/16/2011 37

38.  Infiltrates * Sterile infiltrates * Contact lens * NSAIDS * Immune 1/16/2011 38

39. 1/16/2011 39

40.  Corticosteroid – induced complications *IOP 2% 40 MHG * IOP with fluorometholone 1.5 – 3% with dexametason 25% with dexametason 25% * Herpes keratitis * Ptosis * Cataract 1/16/2011 40

41. 1/16/2011 41

42. * 33% on the lasik patients * Contact lens intolerans * Puctate keratitis * Epithelial haze * Loos Epithelelium 1/16/2011 42

43.  Endothelial effects  Contact lens polymegatisam  Mytomycin complications 1/16/2011 43

44. 1/16/2011 44

45.  Microkeratom complications  Thin flap  Button hol * Irrigular astigmatism 1/16/2011 45

46.  Free cap  Corneal perforation  Epithelial ingrowth 1/16/2011 46

47. 1/16/2011 47

48.  Epithelial erosions  Striae  Flap Subluxation  Traumatic flap dislocation 1/16/2011 48

49. 1/16/2011 49

50. 1/16/2011 50

51. 1/16/2011 51

52.  Dry eye  Central islands  Interface inflamation  Infectious Keratitis 1/16/2011 52

53.  Interface debris  Ectasia 1/16/2011 53

54. 1/16/2011 54

55. 1/16/2011 55

56. 1/16/2011 56

57. 1/16/2011 57

58. 1/16/2011 58

59. 1/16/2011 59

60. 1/16/2011 60

61. 1/16/2011 61

62.  Artisan  Artiflex  ICL 1/16/2011 62

63. 1/16/2011 63